| Date Filed | Type | Description |
| 06/09/2023 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Granted 23,742 options to buy
@ $5.91, valued at
$140.3k
|
|
| 02/07/2023 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 12/08/2022 |
4/A
| Zakrzewski Joseph S (Director) has filed a Form 4 on Cyteir Therapeutics, Inc. |
| 12/08/2022 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Bought 21,202 shares
@ $1.3, valued at
$27.6k
|
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Converted 98,199 shares
@ $0
Converted 98,199 convertible preferred
@ $0 |
|
| 03/24/2022 |
3
| Zakrzewski Joseph S (Director) has filed a Form 3 on AN2 Therapeutics, Inc. |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2021 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Bought 200 shares
@ $9.87, valued at
$2k
Bought 200 shares
@ $9.97, valued at
$2k
Bought 99 shares
@ $10.18, valued at
$1k
Bought 601 shares
@ $9.85, valued at
$5.9k
|
|
| 12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Unknown transaction of 34,499 shares
@ $0
Disposed/sold 10,000 options to buy
@ $27.97, valued at
$279.7k
Disposed/sold 7,500 options to buy
@ $30.17, valued at
$226.3k
Disposed/sold 7,500 options to buy
@ $40.61, valued at
$304.6k
Disposed/sold 10,000 options to buy
@ $41.2, valued at
$412k
Disposed/sold 7,500 options to buy
@ $41.64, valued at
$312.3k
Disposed/sold 8,185 options to buy
@ $52.99, valued at
$433.7k
Disposed/sold 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 6,748 shares
@ $140.31, valued at
$946.8k
Sold 2,152 shares
@ $141.28, valued at
$304k
Sold 1,100 shares
@ $142.27, valued at
$156.5k
Exercised 10,000 options to buy
@ $24.11, valued at
$241.1k
|
|
| 04/02/2021 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Sold 104 shares
@ $132.61, valued at
$13.8k
Sold 6,596 shares
@ $134.27, valued at
$885.6k
Sold 1,700 shares
@ $135.22, valued at
$229.9k
Sold 1,600 shares
@ $135.67, valued at
$217.1k
Exercised 10,000 options to buy
@ $24.11, valued at
$241.1k
|
|
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,622 shares
@ $0
Granted 3,222 options to buy
@ $115.53, valued at
$372.2k
|
|
| 10/22/2020 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Exercised 100,000 options to buy
@ $3.4, valued at
$340k
|
|
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2020 |
4/A
| Zakrzewski Joseph S (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 05/20/2020 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $10.46, valued at
$156.9k
|
|
| 03/19/2020 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Bought 5,000 shares
@ $4.99, valued at
$25k
|
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2020 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Granted 1,377 shares
@ $0
Granted 8,185 options to buy
@ $52.99, valued at
$433.7k
|
|
| 01/09/2020 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on ACCELERON PHARMA INC|
Txns:
| Exercised 18,750 options to buy
@ $3.88, valued at
$72.8k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2019 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Sold 100,000 shares
@ $25.8338, valued at
$2.6M
Exercised 100,000 options to buy
@ $9, valued at
$900k
|
|
| 07/05/2019 |
4
| Zakrzewski Joseph S (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Sold 100,000 shares
@ $23.8158, valued at
$2.4M
Exercised 100,000 options to buy
@ $9, valued at
$900k
|
|
|